- Home
- Applications
- asia middle east
- blood testing
Show results for
Refine by
Blood Testing Product Applications Available In In Asia Middle East
18 applications found
In today’s world, access to essential services, even ones as simple and critical as a blood test, can be a ...
ByAtiva Medical based in Shoreview, MINNESOTA (USA)
Whole blood testing in low volume clinics without incurring high capital costs for large ...
ByProxim Diagnostics Corp. based in Santa Clara, CALIFORNIA (USA)
We are collaborating with leading hospitals, integrated health systems, medical centers and biobanks around the world to conduct studies in order to further develop and validate UDX's blood test for early cancer ...
ByUniversal Diagnostics SL based in Seville, SPAIN
A liquid biopsy from Biocept gives you a new tool for profiling breast cancer—with a simple blood ...
ByBiocept based in San Diego, CALIFORNIA (USA)
Standard diagnostic methods such as skin tests are at times impossible or difficult to perform, have limited reliability and must be performed by trained Allergy and Asthma Specialists. Similarly, laboratory blood tests for specific immunoglobulin E (sIgE) levels have a long turnaround time until results, thus delaying treatment up to several days and requiring multiple visits. ...
ByAbionic SA based in Epalinges, SWITZERLAND
Medica has redefined blood gas analysis, allowing blood tests for critically ill and emergency patients to be performed rapidly and accurately. ...
ByMedica Corporation based in Bedford, MASSACHUSETTS (USA)
It is estimated that there are nearly 137 Million Emergency Room Visits per year in the United States ...
ByAtiva Medical based in Shoreview, MINNESOTA (USA)
Iron deficiency affects up to one third of the world’s population and is one of the leading risk factors for disability and death worldwide 1. Yet, it is still underdiagnosed and undertreated 2. Iron is essential for the body’s proper functioning and is needed to maintain energy levels and concentration, thus, an iron deficiency can leave patients feeling fatigued, unable to concentrate and cold. It is therefore essential to assess the body’s iron reserves. Ferritin has been scientifically and ...
ByAbionic SA based in Epalinges, SWITZERLAND
The future of Continuous Glucose Monitoring (CGM) is here ...
BySenseonics based in Germantown, MARYLAND (USA)
In the Primary Care segment, blood and urine tests drive nearly 70% of Physician decisions, guiding nearly two-thirds of healthcare ...
ByAtiva Medical based in Shoreview, MINNESOTA (USA)
You need a complete answer to provide the best ...
ByBiocept based in San Diego, CALIFORNIA (USA)
The diagnosis of heart failure typically starts when a patient talks to their caregiver about the signs and symptoms they are experiencing. Their health care provider may ask questions designed to confirm the causes of heart failure that may be in their medical history as ...
ByImpulse Dynamics based in Marlton, NEW JERSEY (USA)
The Ankle Brachial Index is a standard and common method of physiologic assessment of vascular pathology in the lower limbs in a fast and simple ...
ByViasonix based in Ra’anana, ISRAEL
Lower extremity Segmental Blood Pressures (SBP) diagnosis refers to the measurement of the systolic blood pressure at various sites along each ...
ByViasonix based in Ra’anana, ISRAEL
ATIVA’s rapid low-cost COVID-19 test may provide earlier detection and a safer community. The greatest challenge we face is the spread of infection before symptoms appear. We all want to protect our loved ones, so how do we know if we are carrying the virus? Physical symptoms (fever, cough) appear too late to stop the spread. The nasal swab PCR tests suffer from sampling errors, slow time to results, and are expensive. Early detection of infected people is the key to protecting our most vulnerable people in ...
ByAtiva Medical based in Shoreview, MINNESOTA (USA)
Standard treatment for advanced colorectal cancer generally involves surgical resection and chemotherapy. However, the recent emergence of targeted therapies, particularly those that inhibit EGFR, has provided treatment options that extend survival for a subset of patients. Unfortunately, this benefit does not extend to patients whose tumors contain mutations in EGFR signaling components KRAS and BRAF, which together represent 50% of all colorectal cancers. This makes characterizing these molecular markers an ...
ByBiocept based in San Diego, CALIFORNIA (USA)
Peripheral Arterial Disease (PAD) is a growing public health issue affecting 202 million people worldwide.1 It is an obstruction of the blood flow in the peripheral arteries, most commonly to the lower limbs and ...
ByQT Vascular Ltd. based in , SINGAPORE
Non-small cell lung cancer (NSCLC) is not a single disease, but a collection of cancer types whose pathology is classified by histology (cells) and molecular profiling (genetic and protein ...
ByBiocept based in San Diego, CALIFORNIA (USA)